Profession

Members of The Medicine Maker 2022 Power List reveal fascinating facts about themselves.

Tom Mander, Chief Executive Officer of Domainex looks back on his career in small molecules and shares his hopes for the future.

Academia-industry collaboration doesn’t have to be difficult; we just need to appreciate one another’s differences.

This is the story of how DNDi put forward a new model for collaborative, open science.

What links the DNDi and one of Google’s most futuristic AI assets? We get the story from DeepMind’s protein premier.

What are the biggest lessons that the pharma industry has learned from the COVID-19 pandemic?

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown

Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.

How AI can be leveraged to improve patient acquisition.